Latest Commercialisation News

Diatreme Resources has announced a substantial upgrade to its Northern Silica Project’s Si2 Deposit, increasing the Measured Mineral Resource by 278% to 187.5 million tonnes. This milestone sets the stage for an upcoming Pre-Feasibility Study targeting a long-life silica sand operation.

Magnetic Resources NL has announced a significant 22% increase in the Lady Julie Gold Project resource, now totaling 2.14 million ounces, boosting the overall Laverton region resource to 2.32 million ounces. This upgrade reflects enhanced confidence in mineral continuity and advances the project closer to development.

Eden Innovations is set to consolidate its shares and launch a $6.6 million entitlement offer to reduce debt and fund global expansion of its EdenCrete® and OptiBlend® products.

Argenica Therapeutics has won up to $1.5 million in non-dilutive government funding to support its late-stage clinical trial of ARG-007, a promising treatment for acute ischaemic stroke.

Proteomics International has launched PromarkerD, a pioneering blood test that predicts diabetic kidney disease years before symptoms, marking its entry into the vast US healthcare market.

Provaris Energy has signed a pivotal Memorandum of Understanding with global shipping giant K LINE to advance the commercialisation of compressed hydrogen carriers, targeting Europe's growing hydrogen import demand by 2030.

Orthocell’s new study confirms Remplir™ delivers superior nerve regeneration and faster muscle recovery compared to traditional sutures, bolstering its US market rollout plans.

TALi Digital has successfully raised $800,000 through a private placement to fuel the commercialisation of its digital health products aimed at enhancing childhood cognitive attention.

Mayne Pharma shareholders have overwhelmingly approved a scheme for Cosette Pharmaceuticals to acquire the company, setting the stage for a pivotal court hearing later this year.

Lithium Universe has acquired exclusive global rights to a pioneering microwave-based solar panel recycling technology from Macquarie University, aiming to revolutionize critical metal recovery and sustainability in the solar industry.

Lumos Diagnostics has enrolled 500 patients in its FebriDx CLIA waiver clinical study, unlocking a significant milestone payment from BARDA and moving closer to FDA approval that could open a US$1 billion market.

Bass Oil Limited reported steady oil production in May with a 3% increase in output and announced plans to acquire the Vanessa gas field, marking a strategic pivot towards gas production in Australia’s evolving energy landscape.